Hakozaki M - Search Results

1

Atypical Fracture of the Scapular Spine: A Case Report.

Mashiko R, Hakozaki M, Kaneuchi Y, Nikaido T, Matsumoto Y. Mashiko R, et al. Among authors: hakozaki m. Cureus. 2024 May 13;16(5):e60237. doi: 10.7759/cureus.60237. eCollection 2024 May. Cureus. 2024. PMID: 38872707 Free PMC article.

2

Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.

Ohishi J, Aoki M, Nabeshima K, Suzumiya J, Takeuchi T, Ogose A, Hakozaki M, Yamashita Y, Iwasaki H. Ohishi J, et al. Among authors: hakozaki m. BMC Cancer. 2013 May 4;13:224. doi: 10.1186/1471-2407-13-224. BMC Cancer. 2013. PMID: 23642185 Free PMC article.

3

Identification and metastatic potential of tumor-initiating cells in malignant rhabdoid tumor of the kidney.

Yanagisawa S, Kadouchi I, Yokomori K, Hirose M, Hakozaki M, Hojo H, Maeda K, Kobayashi E, Murakami T. Yanagisawa S, et al. Among authors: hakozaki m. Clin Cancer Res. 2009 May 1;15(9):3014-22. doi: 10.1158/1078-0432.CCR-08-2237. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383826

4

Mesenchymal chondrosarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients.

Tsuda Y, Ogura K, Hakozaki M, Kikuta K, Ae K, Tsuchiya H, Iwata S, Ueda T, Kawano H, Kawai A. Tsuda Y, et al. Among authors: hakozaki m. J Surg Oncol. 2017 May;115(6):760-767. doi: 10.1002/jso.24567. J Surg Oncol. 2017. PMID: 29044531

5

Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2.

Hakozaki M, Hojo H, Sato M, Tajino T, Yamada H, Kikuchi S, Abe M. Hakozaki M, et al. Anticancer Res. 2006 Sep-Oct;26(5A):3393-401. Anticancer Res. 2006. PMID: 17094458 Free article.

6

Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma.

Bekki H, Kohashi K, Maekawa A, Yamada Y, Yamamoto H, Harimaya K, Hakozaki M, Nabeshima K, Iwamoto Y, Oda Y. Bekki H, et al. Among authors: hakozaki m. BMC Cancer. 2015 Oct 26;15:804. doi: 10.1186/s12885-015-1830-8. BMC Cancer. 2015. PMID: 26502919 Free PMC article.

7

Phosphorylation of STAT3 in Undifferentiated Pleomorphic Sarcoma Is Correlated with a Favorable Prognosis.

Bekki H, Kohashi K, Yamada Y, Iura K, Ishii T, Maekawa A, Otsuka H, Yamamoto H, Hakozaki M, Nabeshima K, Iwamoto Y, Oda Y. Bekki H, et al. Among authors: hakozaki m. Pathobiology. 2017;84(3):161-169. doi: 10.1159/000448524. Epub 2016 Sep 22. Pathobiology. 2017. PMID: 27652596

8

Establishment and characterization of a new cell line, FRTK-1, derived from human malignant rhabdoid tumor of the kidney, with overexpression of epidermal growth factor receptor and cyclooxygenase-2.

Hakozaki M, Hojo H, Sato M, Kaneko Y, Watanabe N, Kikuchi S, Abe M. Hakozaki M, et al. Oncol Rep. 2006 Aug;16(2):265-71. Oncol Rep. 2006. PMID: 16820901

9

Ewing's sarcoma in the spinal nerve root: a case report and review of the literature.

Isefuku S, Seki M, Tajino T, Hakozaki M, Asano S, Hojo H, Hatori M. Isefuku S, et al. Among authors: hakozaki m. Tohoku J Exp Med. 2006 Aug;209(4):369-77. doi: 10.1620/tjem.209.369. Tohoku J Exp Med. 2006. PMID: 16864960 Free article.

10

Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).

Hakozaki M, Hojo H, Kikuchi S, Abe M. Hakozaki M, et al. Oncol Rep. 2007 Jan;17(1):169-73. Oncol Rep. 2007. PMID: 17143495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters